Advertisement
Advertisement
IVVD
Invivyd, Inc. Common Stock
1.47
USDSponsored
-0.02
-1.34%
May 13, 15:54 UTC -4
Closed
Pre-Market
1.49
+0.02
+1.02%
IVVD Earnings Reports
Positive Surprise Ratio
IVVD beat 10 of 19 last estimates.
53%
Next Report
Today BMO
Date of Next Report
May 14, 2026
Estimate for Q1 26 (Revenue/ EPS)
$18.41M
/-$0.07
Implied change from Q-- -- (Revenue/ EPS)
--
/--
Implied change from Q1 25 (Revenue/ EPS)
+62.87%
/-50.00%
Invivyd, Inc. Common Stock earnings per share and revenue
On --, IVVD reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q1 26, 5 analysts forecast an EPS of -0.07 USD, with revenue projected to reach 18.41 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Kamada Ltd
Report Date
May 13, 2026 For Q1 26
Estimate
$0.11
Actual
$0.07
Surprise
-40.32%
Abeona Therapeutics Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.36
Actual
-$0.30
Surprise
+17.31%
Milestone Pharmaceuticals Inc. Common Shares
Report Date
May 13, 2026 For Q1 26
Estimate
$0.31
Actual
-$0.20
Surprise
-163.94%
Spero Therapeutics, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.18
Actual
-$0.13
Surprise
+29.19%
Equillium, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.04
Actual
-$0.06
Surprise
-34.53%
Spruce Biosciences, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$8.99
Actual
-$8.94
Surprise
+0.58%
BeyondSpring Inc. Ordinary Shares
Report Date
May 13, 2026 For Q1 26
Estimate
-Actual
-$0.05
Surprise
-
Tango Therapeutics, Inc.
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.31
Actual
-$0.32
Surprise
-0.13%
Longeveron Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.16
Actual
-$0.19
Surprise
-12.89%
Bionano Genomics, Inc. Common Stock
Report Date
May 13, 2026 For Q1 26
Estimate
-$0.96
Actual
-$0.76
Surprise
+21.57%
FAQ
What were Invivyd, Inc. Common Stock's earnings and revenue for the latest quarter Q-- --?
For Q-- --, Invivyd, Inc. Common Stock reported EPS of --, Inline estimates by --, and revenue of --, -- -- expectations.
How did the market react to Invivyd, Inc. Common Stock's Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Invivyd, Inc. Common Stock expected to report next?
The next earning report is scheduled for May 14, 2026.
What are the forecasts for Invivyd, Inc. Common Stock's next earnings report?
Based on 5
analysts, Invivyd, Inc. Common Stock is expected to report EPS of -$0.07 and revenue of $18.41M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement